MING MEDICAL SERVICES
Giving hope, where there is none
Hosp
STEM CELL RESEARCH

Insulin Resistance

Efficacy of Human Umbilical Cord Blood-Derived Stem Cells And Exosomes To Overcome Insulin Resistance In Diabetes Mellitus Type 2

Phase 1

  • Isolation of human Mesenchymal Stem Cells (MSC)
  • Characterization of MSC

Phase 2

  • Differentiation of MSC into pancreatic cells
  • Characterization of pancreatic cells
  • Isolation of Exocomes

Phase 3
Pre-clinical trial in Diabetic rat model

  1. Pancreatic cell treatment
  2. Exosomes treatment

New Research
  • Establish pancreatic beta cell-line from human umbilical cord blood-Mesenchymal Stem Cells (hUCB-MSC)
  • Human exosomes production
  • New cocktail (Stem cells & Exosomes) to eliminate insulin resistance in Diabetes Type 2

Conducted By:


Copyright 2011-2018 Ming Medical Services. All Rights Reserved